JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
iShares MSCI Emerging Markets ETF
EEM
$31.5B
| $372M | 0.09% |
8,984,144
+6,710,818
| +295% | +$273M |
2013 Q2
16 quarters
|
|
252
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $369M | 0.08% |
9,049,443
+2,339,786
| +35% | +$94.8M |
2013 Q2
16 quarters
|
|
|
CMA
253
DELISTED
Comerica
CMA
| $369M | 0.08% |
5,040,167
+919,333
| +22% | +$64.5M |
2013 Q2
16 quarters
|
|
254
PVH
PVH
$3.48B
| $369M | 0.08% |
3,219,010
+13,101
| +0.4% | +$1.36M |
2013 Q2
16 quarters
|
|
255
Duke Energy
DUK
$89B
| $368M | 0.08% |
4,405,713
+2,301,272
| +109% | +$193M |
2013 Q2
16 quarters
|
|
256
WEX
WEX
$5.76B
| $368M | 0.08% |
3,524,870
+701,688
| +25% | +$72.2M |
2013 Q2
16 quarters
|
|
257
Williams Companies
WMB
$86.3B
| $366M | 0.08% |
12,100,909
+1,975,398
| +20% | +$58.8M |
2013 Q2
16 quarters
|
|
258
Oracle
ORCL
$431B
| $361M | 0.08% |
7,206,808
-1,850,819
| -20% | -$84.4M |
2013 Q2
16 quarters
|
|
259
Ally Financial
ALLY
$11.5B
| $361M | 0.08% |
17,284,353
-1,095,114
| -6% | -$21.5M |
2014 Q2
12 quarters
|
|
260
Itaú Unibanco
ITUB
$94.7B
| $357M | 0.08% |
66,578,586
-1,551,694
| -2% | -$8.7M |
2013 Q2
16 quarters
|
|
261
Thermo Fisher Scientific
TMO
$242B
| $356M | 0.08% |
2,041,728
-106,314
| -5% | -$17.9M |
2013 Q2
16 quarters
|
|
262
WEC Energy
WEC
$33.1B
| $354M | 0.08% |
5,762,776
+103,009
| +2% | +$6.36M |
2013 Q2
16 quarters
|
|
|
263
Vanguard Morningstar Mid-Cap ETF
VO
$104B
| $352M | 0.08% |
9,873,660
-18,577,040
| -65% | -$656M |
2013 Q2
16 quarters
|
|
264
Copa Holdings
CPA
$5.41B
| $347M | 0.08% |
2,961,624
+270,954
| +10% | +$31.2M |
2013 Q2
16 quarters
|
|
265
Rayonier
RYN
$5.37B
| $344M | 0.08% |
13,188,159
-128,381
| -1% | -$3.31M |
2013 Q2
16 quarters
|
|
|
XL
266
DELISTED
XL Group Ltd.
XL
| $344M | 0.08% |
7,858,462
-175,996
| -2% | -$7.42M |
2013 Q2
16 quarters
|
|
267
Monster Beverage
MNST
$84.1B
| $342M | 0.08% |
27,519,344
+300,584
| +1% | +$3.62M |
2013 Q2
16 quarters
|
|
268
Acadia Healthcare
ACHC
$2.61B
| $341M | 0.08% |
6,907,199
-798,776
| -10% | -$35.4M |
2013 Q2
16 quarters
|
|
269
PUT
iShares MSCI Australia ETF
EWA
$1.21B
| $341M | 0.08% |
9,874,000
+1,877,300
| +23% | +$41.2M |
2013 Q2
16 quarters
|
|
|
WCG
270
DELISTED
Wellcare Health Plans, Inc.
WCG
| $339M | 0.08% |
1,890,174
-32,788
| -2% | -$5.43M |
2013 Q2
16 quarters
|
|
271
CVS Health
CVS
$111B
| $339M | 0.08% |
4,215,572
+55,383
| +1% | +$4.37M |
2013 Q2
16 quarters
|
|
272
Synopsys
SNPS
$93.9B
| $335M | 0.08% |
4,599,984
-290,402
| -6% | -$21.4M |
2013 Q2
16 quarters
|
|
273
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $334M | 0.08% |
5,779,959
+3,204,279
| +124% | +$183M |
2013 Q2
16 quarters
|
|
274
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.59B
| $330M | 0.08% |
2,959,655
+1,779,911
| +151% | +$198M |
2013 Q2
16 quarters
|
|
275
State Street Financial Select Sector SPDR ETF
XLF
$50.6B
| $330M | 0.08% |
13,368,496
+7,212,427
| +117% | +$171M |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.